ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
Oncotarget
◽
10.18632/oncotarget.5463
◽
2015
◽
Vol 6
(38)
◽
pp. 41339-41349
◽
Cited By ~ 30
Author(s):
Shan-Shan Jiang
◽
Yan Tang
◽
Yao-Jun Zhang
◽
De-Sheng Weng
◽
Zhong-Guo Zhou
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Tumor Infiltrating Lymphocytes
◽
Phase I Clinical Trial
◽
Primary Hepatocellular Carcinoma
◽
Autologous Tumor
◽
Infiltrating Lymphocytes
Get full-text (via PubEx)
Related Documents
Cited By
References
352PD A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
Annals of Oncology
◽
10.1093/annonc/mdv528.09
◽
2015
◽
Vol 26
◽
pp. ix103
◽
Cited By ~ 1
Author(s):
S. Jiang
◽
J. Xia
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Tumor Infiltrating Lymphocytes
◽
Phase I Clinical Trial
◽
Primary Hepatocellular Carcinoma
◽
Autologous Tumor
◽
Infiltrating Lymphocytes
Get full-text (via PubEx)
531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results
European Journal of Cancer
◽
10.1016/s0959-8049(16)30332-x
◽
2015
◽
Vol 51
◽
pp. S114
◽
Cited By ~ 3
Author(s):
D. Migliorini
◽
R. Vernet
◽
M.C. Belkouch
◽
P. Luy
◽
S. Blaser
◽
...
Keyword(s):
Clinical Trial
◽
Clinical Outcome
◽
Phase I
◽
Tumor Cells
◽
Phase I Clinical Trial
◽
Autologous Tumor
◽
Cell Technology
Get full-text (via PubEx)
Adoptive Transfer of Autologous Invariant NKT Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial
The Oncologist
◽
10.1002/onco.13899
◽
2021
◽
Author(s):
Yao Gao
◽
Jia Guo
◽
Xuli Bao
◽
Fang Xiong
◽
Yanpin Ma
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Adoptive Transfer
◽
Nkt Cells
◽
Phase I Clinical Trial
◽
Advanced Hepatocellular Carcinoma
◽
Invariant Nkt Cells
Get full-text (via PubEx)
Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma
Cancer Biotherapy & Radiopharmaceuticals
◽
10.1089/1084978042484777
◽
2004
◽
Vol 19
(5)
◽
pp. 589-600
Author(s):
Shaoliang Chen
◽
Beilei Li
◽
Hong Xie
◽
Li Xu
◽
Guangjun Niu
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Targeted Therapy
◽
Phase I
◽
Phase I Clinical Trial
Get full-text (via PubEx)
Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma
Cancer Biotherapy & Radiopharmaceuticals
◽
10.1089/cbr.2004.19.589
◽
2004
◽
Vol 19
(5)
◽
pp. 589-600
◽
Cited By ~ 9
Author(s):
Shaoliang Chen
◽
Beilei Li
◽
Hong Xie
◽
Li Xu
◽
Guangjun Niu
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Targeted Therapy
◽
Phase I
◽
Phase I Clinical Trial
Get full-text (via PubEx)
A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.e14655
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. e14655-e14655
Author(s):
J. Yi
◽
H. Ahn
◽
S. Lee
◽
J. Uhm
◽
J. Lee
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Phase I Clinical Trial
◽
Advanced Hepatocellular Carcinoma
Get full-text (via PubEx)
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma
World Journal of Gastroenterology
◽
10.3748/wjg.v10.i8.1146
◽
2004
◽
Vol 10
(8)
◽
pp. 1146
◽
Cited By ~ 84
Author(s):
Ming Shi
◽
Bing Zhang
◽
Zi-Rong Tang
◽
Zhou-Yun Lei
◽
Hui-Fen Wang
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Cell Therapy
◽
Phase I
◽
Killer Cell
◽
Primary Hepatocellular Carcinoma
◽
Trial Phase
Get full-text (via PubEx)
Abstract 5585: Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma
10.1158/1538-7445.am2012-5585
◽
2012
◽
Author(s):
Jia Jinbin
◽
Xiao Zhen-Yu
◽
Chen Xiao-Ping
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Continuous Infusion
◽
Phase I Clinical Trial
◽
Advanced Hepatocellular Carcinoma
Get full-text (via PubEx)
Preliminary Results of Hepatocellular Carcinoma Patients Treated by Talaporfin Sodium and Interstitial Light Emitting Diodes – A Phase I Clinical Trial
The American Journal of Gastroenterology
◽
10.14309/00000434-200609001-00434
◽
2006
◽
Vol 101
◽
pp. S190
Author(s):
Wei-Chen Lee
◽
Sheng-Nan Lu
◽
Yi-Hong Chou
◽
Jeng-Hwei Tseng
◽
Jing-Houng Wang
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Clinical Trial
◽
Phase I
◽
Light Emitting Diodes
◽
Phase I Clinical Trial
◽
Light Emitting
◽
Talaporfin Sodium
◽
Preliminary Results
Get full-text (via PubEx)
Expression of Inhibitory Receptors in Natural Killer (CD3−CD56+) Cells and CD3+CD56+ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma
Clinical Immunology
◽
10.1006/clim.2001.5110
◽
2001
◽
Vol 101
(3)
◽
pp. 264-269
◽
Cited By ~ 12
Author(s):
Man-Fung Yuen
◽
Suzanne Norris
Keyword(s):
Hepatocellular Carcinoma
◽
Natural Killer
◽
Peripheral Blood
◽
Tumor Infiltrating Lymphocytes
◽
Peripheral Blood Lymphocytes
◽
Primary Hepatocellular Carcinoma
◽
Inhibitory Receptors
◽
Blood Lymphocytes
◽
Infiltrating Lymphocytes
Get full-text (via PubEx)
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close